Literature DB >> 21492992

Nitric oxide metabolites in allergic rhinitis: The effect of pollen allergen exposure.

G Ciprandi1, M Tosca, D Fuchs.   

Abstract

BACKGROUND: Seasonal allergic rhinitis (SAR) is characterised by an inflammation consequent to allergen exposure. Nitric oxide may be involved in allergic inflammation.
OBJECTIVE: This study evaluated the serum nitrite concentrations in SAR patients during and outside pollen exposure in order to estimate activity of nitric oxide synthases.
METHODS: One hundred and two (56 females, 46 males, median age: 28.7 years) were included in this study: 56 with SAR evaluated outside the pollen season and so without allergic inflammation and symptoms, and 46 with SAR evaluated during the pollen season with symptoms. Serum concentrations of nitrite were measured and in those patients exposed to pollens, results were compared to scores of the Visual Analogue Scale for nasal obstruction perception.
RESULTS: Serum nitrite concentrations were higher in SAR patients evaluated outside the pollen season (U=-6.78; p<0.0001), moreover, there was a significant relationship between nasal obstruction perception and nitrite in patients evaluated during the pollen season.
CONCLUSION: This preliminary study demonstrates that serum nitric oxide metabolism depends on allergen exposure.
Copyright © 2010 SEICAP. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21492992     DOI: 10.1016/j.aller.2011.01.001

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  2 in total

1.  Nitrite, neopterin levels and tryptophan degradation in allergic conjunctivitis.

Authors:  Emine Cinici; Saziye Sezin Palabiyik; Hande Sipahi; Terken Baydar
Journal:  Int Ophthalmol       Date:  2017-08-04       Impact factor: 2.031

Review 2.  Tryptophan Metabolism in Allergic Disorders.

Authors:  Johanna M Gostner; Katrin Becker; Heinz Kofler; Barbara Strasser; Dietmar Fuchs
Journal:  Int Arch Allergy Immunol       Date:  2016-05-04       Impact factor: 2.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.